| Code | Description | Claims | Beneficiaries | Total Paid |
| 36415 |
Collection of venous blood by venipuncture |
6,737 |
4,235 |
$462K |
| 80053 |
Comprehensive metabolic panel |
10,465 |
7,206 |
$298K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,048 |
3,448 |
$258K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,208 |
8,857 |
$248K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,870 |
5,662 |
$236K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,377 |
7,379 |
$204K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,535 |
2,208 |
$136K |
| S0028 |
Injection, famotidine, 20 mg |
1,564 |
1,328 |
$132K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
2,474 |
1,154 |
$107K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,001 |
4,992 |
$105K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,878 |
2,495 |
$97K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,704 |
677 |
$94K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,383 |
2,144 |
$93K |
| J3490 |
Unclassified drugs |
595 |
260 |
$90K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,599 |
2,125 |
$69K |
| 81001 |
|
9,193 |
8,074 |
$69K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,262 |
1,109 |
$68K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,942 |
1,565 |
$61K |
| 84703 |
|
7,141 |
6,458 |
$56K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,118 |
409 |
$54K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
631 |
522 |
$49K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,596 |
1,414 |
$40K |
| G0378 |
Hospital observation service, per hour |
7,470 |
2,850 |
$40K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,157 |
1,068 |
$32K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,027 |
871 |
$31K |
| 59025 |
Fetal non-stress test |
642 |
464 |
$28K |
| 82962 |
|
6,157 |
2,061 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
8,718 |
7,214 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,424 |
12,054 |
$22K |
| 81003 |
|
2,447 |
2,151 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,628 |
3,216 |
$18K |
| 87070 |
|
1,944 |
1,754 |
$18K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
991 |
898 |
$17K |
| A9270 |
Non-covered item or service |
3,836 |
1,682 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,732 |
5,763 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,694 |
2,272 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
437 |
368 |
$13K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
876 |
735 |
$13K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,447 |
1,932 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,732 |
5,914 |
$12K |
| J1815 |
Injection, insulin, per 5 units |
537 |
232 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,746 |
3,019 |
$11K |
| 84484 |
|
6,317 |
3,851 |
$10K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
209 |
185 |
$10K |
| 84702 |
|
2,537 |
2,141 |
$8K |
| 85610 |
|
6,472 |
5,338 |
$8K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
52 |
13 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,963 |
5,524 |
$7K |
| 85730 |
|
5,563 |
4,617 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
739 |
351 |
$7K |
| 72131 |
|
359 |
302 |
$6K |
| 87040 |
|
3,448 |
1,736 |
$6K |
| S0030 |
Injection, metronidazole, 500 mg |
409 |
232 |
$6K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,656 |
1,018 |
$5K |
| 82550 |
|
4,311 |
2,557 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
914 |
741 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
989 |
821 |
$4K |
| 80076 |
|
1,687 |
1,447 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,099 |
922 |
$4K |
| 84112 |
|
26 |
24 |
$4K |
| 76830 |
Ultrasound, transvaginal |
157 |
142 |
$4K |
| J0456 |
Injection, azithromycin, 500 mg |
121 |
67 |
$3K |
| 83690 |
|
2,880 |
2,477 |
$3K |
| 73562 |
|
173 |
138 |
$3K |
| 83605 |
|
2,321 |
1,757 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,494 |
3,865 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,093 |
3,521 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,554 |
1,239 |
$3K |
| 83880 |
|
1,775 |
1,443 |
$3K |
| 73030 |
|
303 |
242 |
$3K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
508 |
362 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
424 |
363 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,038 |
879 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,247 |
1,064 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
228 |
159 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,323 |
1,091 |
$2K |
| 76818 |
|
94 |
79 |
$2K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
130 |
90 |
$2K |
| 86900 |
|
1,991 |
1,802 |
$2K |
| 86850 |
|
1,622 |
1,470 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,861 |
3,424 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
571 |
469 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,453 |
910 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
827 |
674 |
$2K |
| 87077 |
|
1,301 |
1,093 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,559 |
2,781 |
$2K |
| 90715 |
|
328 |
277 |
$2K |
| 71250 |
|
201 |
165 |
$2K |
| 73610 |
|
169 |
141 |
$1K |
| 73130 |
|
70 |
52 |
$1K |
| 94664 |
|
880 |
712 |
$1K |
| 87186 |
|
1,298 |
1,094 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
959 |
694 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
26 |
25 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
268 |
206 |
$1K |
| 82803 |
|
850 |
683 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
814 |
721 |
$1K |
| 86901 |
|
1,992 |
1,802 |
$1K |
| 73630 |
|
185 |
147 |
$1K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
537 |
338 |
$982.09 |
| 87205 |
|
270 |
212 |
$960.72 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,985 |
1,868 |
$872.16 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,112 |
981 |
$844.72 |
| 93971 |
|
79 |
70 |
$754.49 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
83 |
57 |
$595.18 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
859 |
575 |
$569.39 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
116 |
100 |
$558.20 |
| 76801 |
|
147 |
136 |
$532.05 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
129 |
73 |
$394.86 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
664 |
436 |
$393.07 |
| J1956 |
Injection, levofloxacin, 250 mg |
323 |
203 |
$389.12 |
| 73110 |
|
49 |
42 |
$385.76 |
| 76775 |
|
25 |
25 |
$384.67 |
| 93970 |
|
67 |
51 |
$314.57 |
| 97597 |
|
23 |
12 |
$278.58 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
851 |
758 |
$213.59 |
| 83735 |
|
1,624 |
915 |
$209.10 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,156 |
588 |
$200.54 |
| 85379 |
|
539 |
422 |
$196.20 |
| 84100 |
|
1,430 |
805 |
$191.26 |
| 97163 |
|
65 |
49 |
$191.09 |
| 36410 |
|
59 |
40 |
$131.48 |
| 74018 |
|
42 |
35 |
$128.74 |
| 82150 |
|
368 |
317 |
$108.58 |
| 93880 |
|
33 |
25 |
$98.64 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
27 |
24 |
$96.84 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
14 |
13 |
$90.91 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
298 |
156 |
$81.46 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
116 |
69 |
$59.78 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
29 |
24 |
$41.91 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
711 |
645 |
$30.91 |
| 80061 |
Lipid panel |
196 |
166 |
$25.36 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
744 |
615 |
$17.36 |
| 86592 |
|
16 |
16 |
$7.51 |
| 87807 |
|
152 |
151 |
$4.91 |
| 86140 |
|
117 |
87 |
$2.88 |
| 70486 |
|
15 |
13 |
$2.40 |
| 88304 |
|
123 |
118 |
$2.32 |
| 87210 |
|
15 |
13 |
$1.92 |
| 87320 |
|
14 |
13 |
$1.44 |
| 87081 |
|
15 |
14 |
$1.44 |
| 83615 |
|
76 |
59 |
$0.96 |
| J1940 |
Injection, furosemide, up to 20 mg |
30 |
18 |
$0.96 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
15 |
13 |
$0.92 |
| 82728 |
|
134 |
103 |
$0.48 |
| 73564 |
|
21 |
17 |
$0.46 |
| 97166 |
|
13 |
12 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
28 |
28 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$0.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
17 |
13 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
24 |
16 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
17 |
15 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
49 |
40 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
95 |
75 |
$0.00 |
| 88312 |
|
45 |
39 |
$0.00 |
| 99218 |
|
62 |
26 |
$0.00 |
| 84145 |
|
18 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$0.00 |